Mostrar el registro sencillo del ítem

dc.contributor.author
McCoy, Laura E.  
dc.contributor.author
Rutten, Lucy  
dc.contributor.author
Frampton, Dan  
dc.contributor.author
Anderson, Ian  
dc.contributor.author
Granger, Luke  
dc.contributor.author
Bashford Rogers, Rachael  
dc.contributor.author
Dekkers, Gillian  
dc.contributor.author
Strokappe, Nika M.  
dc.contributor.author
Seaman, Michael S.  
dc.contributor.author
Koh, Willie  
dc.contributor.author
Grippo, Vanina  
dc.contributor.author
Kliche, Alexander  
dc.contributor.author
Verrips, Theo  
dc.contributor.author
Kellam, Paul  
dc.contributor.author
Fassati, Ariberto  
dc.contributor.author
Weiss, Robin A.  
dc.date.available
2016-02-11T19:53:04Z  
dc.date.issued
2014-12  
dc.identifier.citation
McCoy, Laura E.; Rutten, Lucy; Frampton, Dan; Anderson, Ian; Granger, Luke; et al.; Molecular evolution of broadly neutralizing llama antibodies to the CD4-binding site of HIV-1; Public Library of Science; Plos Pathogens; 10; 12; 12-2014; e1004552-e1004552  
dc.identifier.issn
1553-7366  
dc.identifier.uri
http://hdl.handle.net/11336/4155  
dc.description.abstract
To date, no immunization of humans or animals has elicited broadly neutralizing sera able to prevent HIV-1 transmission; however, elicitation of broad and potent heavy chain only antibodies (HCAb) has previously been reported in llamas. In this study, the anti-HIV immune responses in immunized llamas were studied via deep sequencing analysis using broadly neutralizing monoclonal HCAbs as a guides. Distinct neutralizing antibody lineages were identified in each animal, including two defined by novel antibodies (as variable regions called VHH) identified by robotic screening of over 6000 clones. The combined application of five VHH against viruses from clades A, B, C and CRF_AG resulted in neutralization as potent as any of the VHH individually and a predicted 100% coverage with a median IC50 of 0.17 µg/ml for the panel of 60 viruses tested. Molecular analysis of the VHH repertoires of two sets of immunized animals showed that each neutralizing lineage was only observed following immunization, demonstrating that they were elicited de novo. Our results show that immunization can induce potent and broadly neutralizing antibodies in llamas with features similar to human antibodies and provide a framework to analyze the effectiveness of immunization protocols.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Public Library of Science  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by/2.5/ar/  
dc.subject
Neutralizing Llama Antibodies  
dc.subject
Hiv-1  
dc.subject
Cd4-Binding Site  
dc.subject
Molecular Evolution  
dc.subject.classification
Virología  
dc.subject.classification
Ciencias Biológicas  
dc.subject.classification
CIENCIAS NATURALES Y EXACTAS  
dc.title
Molecular evolution of broadly neutralizing llama antibodies to the CD4-binding site of HIV-1  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2016-03-30 10:35:44.97925-03  
dc.journal.volume
10  
dc.journal.number
12  
dc.journal.pagination
e1004552-e1004552  
dc.journal.pais
Estados Unidos  
dc.journal.ciudad
San Francisco  
dc.description.fil
Fil: McCoy, Laura E.. University College London. Division of Infection and Immunity. Centre for Medical Molecular Virology. Wohl Virion Centre and Medical Research Council; Reino Unido  
dc.description.fil
Fil: Rutten, Lucy. QVQ B.V.; Países Bajos  
dc.description.fil
Fil: Frampton, Dan. University College London. Division of Infection and Immunity. Centre for Medical Molecular Virology. Wohl Virion Centre and Medical Research Council; Reino Unido  
dc.description.fil
Fil: Anderson, Ian. University College London. Division of Infection and Immunity. Centre for Medical Molecular Virology. Wohl Virion Centre and Medical Research Council; Reino Unido  
dc.description.fil
Fil: Granger, Luke. King’s College London. School of Medicine. Guy’s Hospital. Department of Infectious Diseases; Reino Unido  
dc.description.fil
Fil: Bashford Rogers, Rachael. Wellcome Trust Sanger Institute; Reino Unido  
dc.description.fil
Fil: Dekkers, Gillian. University College London. Division of Infection and Immunity. Centre for Medical Molecular Virology. Wohl Virion Centre and Medical Research Council; Reino Unido  
dc.description.fil
Fil: Strokappe, Nika M.. QVQ B.V.; Países Bajos  
dc.description.fil
Fil: Seaman, Michael S.. Harvard Medical School. Beth Israel Deaconess Medical Center. Center for Virology and Vaccine Research; Estados Unidos  
dc.description.fil
Fil: Koh, Willie. University College London. Division of Infection and Immunity. Centre for Medical Molecular Virology. Wohl Virion Centre and Medical Research Council; Reino Unido  
dc.description.fil
Fil: Grippo, Vanina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Ciencias y Tecnología "Dr. Cesar Milstein"; Argentina  
dc.description.fil
Fil: Kliche, Alexander. University of Regensburg. Institute of Medical Microbiology; Alemania  
dc.description.fil
Fil: Verrips, Theo. QVQ B.V.; Países Bajos  
dc.description.fil
Fil: Kellam, Paul. Wellcome Trust Sanger Institute; Reino Unido  
dc.description.fil
Fil: Fassati, Ariberto. University College London. Division of Infection and Immunity. Centre for Medical Molecular Virology. Wohl Virion Centre and Medical Research Council; Reino Unido  
dc.description.fil
Fil: Weiss, Robin A.. University College London. Division of Infection and Immunity. Centre for Medical Molecular Virology. Wohl Virion Centre and Medical Research Council; Reino Unido  
dc.journal.title
Plos Pathogens  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1004552  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://dx.doi.org/DOI:10.1371/journal.ppat.1004552  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/issn/1553-7366  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://www.ncbi.nlm.nih.gov/pubmed/25522326